Eloralintide
ENLIGHTEN-2
Eli Lilly · Phase 3 · Recruiting · Enrollment 1035
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Eloralintide Dose 1 | Obesity or overweight | n/r | 75 | n/r | n/r |
| Eloralintide Dose 2 | Obesity or overweight | n/r | 75 | n/r | n/r |
| Eloralintide Dose 3 | Obesity or overweight | n/r | 75 | n/r | n/r |
| Eloralintide Dose 4 | Obesity or overweight | n/r | 75 | n/r | n/r |
| Placebo | Obesity or overweight | n/r | 75 | n/r | n/r |